Back
WisdomTree Emerging Markets SmCp Div ETF Vs. Viking Therapeutics Industry Stock Comparison
Buy
61
DGS
WisdomTree Emerging Markets SmCp Div ETF
Last Price:
51.59
Seasonality Move:
-0.92%
Buy
53
VKTX
Viking Therapeutics
Last Price:
62.28
Seasonality Move:
10.92%
Buy
61
WisdomTree Emerging Markets SmCp Div ETF (DGS)
is a Buy
Is WisdomTree Emerging Markets SmCp Div ETF a Buy, Sell or Hold?
- The current WisdomTree Emerging Markets SmCp Div ETF [DGS] share price is $51.60. The Score for DGS is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- DGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
53
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $62.30. The Score for VKTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DGS Stock Price Chart
What is WisdomTree Emerging Markets SmCp Div ETF's stock price today?
-
The WisdomTree Emerging Markets SmCp Div ETF share price today is $51.60
The current trend is moderately bearish and DGS is experiencing slight buying pressure.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $62.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
DGS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 45.48 | Sell |
| Chaikin Money Flow: | 126798 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.45 - 52.67) | Sell |
| Bollinger Bands (100): | (48.94 - 51.78) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.68 | Sell |
| Relative Strength Index (14 RSI): | 39.56 | Sell |
| Chaikin Money Flow: | -369406 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.67 - 77.83) | Sell |
| Bollinger Bands (100): | (34.63 - 80.19) | Buy |
DGS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 52.21 | Sell |
| 20-day SMA: | 52.28 | Sell |
| 50-day SMA: | 51.37 | Buy |
| 200-day SMA: | 48.74 | Buy |
| 8-day EMA: | 52.09 | Sell |
| 20-day EMA: | 52.04 | Sell |
| 50-day EMA: | 51.43 | Buy |
| 200-day EMA: | 49.36 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.1 | Sell |
| 20-day SMA: | 69.99 | Sell |
| 50-day SMA: | 71.49 | Sell |
| 200-day SMA: | 35.49 | Buy |
| 8-day EMA: | 64.06 | Sell |
| 20-day EMA: | 67.39 | Sell |
| 50-day EMA: | 67.06 | Sell |
| 200-day EMA: | 44.16 | Buy |
WisdomTree Emerging Markets SmCp Div ETF Earnings Growth & DGS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.44 per share.
WisdomTree Emerging Markets SmCp Div ETF Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||